Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14310329
[patent_doc_number] => 20190144868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis
[patent_app_type] => utility
[patent_app_number] => 16/041381
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041381
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/041381 | Products and methods for treatment of familial amyotrophic lateral sclerosis | Jul 19, 2018 | Issued |
Array
(
[id] => 14098949
[patent_doc_number] => 20190091150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/025557
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025557 | POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME | Jul 1, 2018 | Abandoned |
Array
(
[id] => 13827177
[patent_doc_number] => 20190017073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL
[patent_app_type] => utility
[patent_app_number] => 16/025503
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025503
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025503 | COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL | Jul 1, 2018 | Abandoned |
Array
(
[id] => 16894300
[patent_doc_number] => 11035847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Deterministic stepping of polymers through a nanopore
[patent_app_type] => utility
[patent_app_number] => 16/022594
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 11862
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16022594
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/022594 | Deterministic stepping of polymers through a nanopore | Jun 27, 2018 | Issued |
Array
(
[id] => 15239733
[patent_doc_number] => 20190374652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => METHODS AND COMPOSITIONS FOR INCREASING SIALIC ACID PRODUCTION AND TREATING SIALIC RELATED DISEASE CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/006767
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16006767
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/006767 | METHODS AND COMPOSITIONS FOR INCREASING SIALIC ACID PRODUCTION AND TREATING SIALIC RELATED DISEASE CONDITIONS | Jun 11, 2018 | Abandoned |
Array
(
[id] => 16013607
[patent_doc_number] => 20200181646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => SELF-REGULATING AAV VECTORS FOR SAFE EXPRESSION OF MECP2 IN RETT SYNDROME
[patent_app_type] => utility
[patent_app_number] => 16/619733
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619733 | Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome | Jun 5, 2018 | Issued |
Array
(
[id] => 13586655
[patent_doc_number] => 20180344876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Vectors Conditionally Expressing Protein
[patent_app_type] => utility
[patent_app_number] => 15/993773
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15993773
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/993773 | Vectors Conditionally Expressing Protein | May 30, 2018 | Abandoned |
Array
(
[id] => 17306258
[patent_doc_number] => 11207340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Tumor suppressor TET1 and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/988619
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 33
[patent_no_of_words] => 17142
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988619
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/988619 | Tumor suppressor TET1 and uses thereof | May 23, 2018 | Issued |
Array
(
[id] => 16703131
[patent_doc_number] => 10953044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Functionalized tissue matrices
[patent_app_type] => utility
[patent_app_number] => 15/987132
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11997
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987132
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/987132 | Functionalized tissue matrices | May 22, 2018 | Issued |
Array
(
[id] => 15782497
[patent_doc_number] => 10624951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => SRPX for treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 15/985992
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 8751
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985992
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985992 | SRPX for treatment of cancer | May 21, 2018 | Issued |
Array
(
[id] => 16298032
[patent_doc_number] => 20200283755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING
[patent_app_type] => utility
[patent_app_number] => 16/614549
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614549
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614549 | Systems, methods, and compositions for targeted nucleic acid editing | May 17, 2018 | Issued |
Array
(
[id] => 17407343
[patent_doc_number] => 11248214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Compositions and methods for enhanced gene expression in cone cells
[patent_app_type] => utility
[patent_app_number] => 15/984085
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 28
[patent_no_of_words] => 29166
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984085 | Compositions and methods for enhanced gene expression in cone cells | May 17, 2018 | Issued |
Array
(
[id] => 13622951
[patent_doc_number] => 20180363027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => STABILIZING COMPOSITIONS AND METHODS FOR EXTRACTION OF RIBONUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 15/980682
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15980682
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/980682 | Stabilizing compositions and methods for extraction of ribonucleic acid | May 14, 2018 | Issued |
Array
(
[id] => 16087103
[patent_doc_number] => 20200197538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => Systemic Delivery of Polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/612648
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612648
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612648 | Systemic delivery of polypeptides | May 13, 2018 | Issued |
Array
(
[id] => 13586459
[patent_doc_number] => 20180344778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Methods of Enhancing Female Fertility
[patent_app_type] => utility
[patent_app_number] => 15/976413
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15976413
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/976413 | Methods of enhancing female fertility | May 9, 2018 | Issued |
Array
(
[id] => 13397593
[patent_doc_number] => 20180250339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => METHODS AND COMPOSITIONS FOR GENE EDITING IN HEMATOPOIETIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 15/970605
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970605
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/970605 | Methods and compositions for gene editing in hematopoietic stem cells | May 2, 2018 | Issued |
Array
(
[id] => 15899001
[patent_doc_number] => 20200149019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/604427
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604427
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604427 | Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells | Apr 12, 2018 | Issued |
Array
(
[id] => 18620406
[patent_doc_number] => 11753434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Compositions and methods for transient gene therapy with enhanced stability
[patent_app_type] => utility
[patent_app_number] => 16/604609
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 62
[patent_no_of_words] => 16606
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604609
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604609 | Compositions and methods for transient gene therapy with enhanced stability | Apr 12, 2018 | Issued |
Array
(
[id] => 13479587
[patent_doc_number] => 20180291336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => METHOD OF MANUFACTURING AND PURIFYING EXOSOMES FROM NON-TERMINALLY DIFFERENTIATED CELLS
[patent_app_type] => utility
[patent_app_number] => 15/947329
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947329
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/947329 | METHOD OF MANUFACTURING AND PURIFYING EXOSOMES FROM NON-TERMINALLY DIFFERENTIATED CELLS | Apr 5, 2018 | Abandoned |
Array
(
[id] => 13343639
[patent_doc_number] => 20180223359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => CONJUGATED POLYMERIC PARTICLE AND METHOD OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 15/945348
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945348
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/945348 | Conjugated polymeric particle and method of making same | Apr 3, 2018 | Issued |